Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib

van der Veen, L; Schmitt, M; Deken, MA; Lahn, M

van der Veen, L (通讯作者)，iOnctura BV, Oncol Dept, Amsterdam, Netherlands.;van der Veen, L (通讯作者)，iOnctura BV, Gustav Mahlerpl 102, NL-1082 MA Amsterdam, Netherlands.

INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023; 42 (6): 515

Abstract

Roginolisib (IOA-244) is a novel, non-ATP competitive phosphoinositide-3-kinase (PI3K) delta inhibitor that regulates Akt/mTOR signaling. Roginolisib ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索